HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young Joo Lee Selected Research

Messenger RNA (mRNA)

11/2018Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
7/2017Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma.
1/2003Ginsenoside Rc and Re stimulate c-fos expression in MCF-7 human breast carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young Joo Lee Research Topics

Disease

30Neoplasms (Cancer)
08/2022 - 10/2004
12Breast Neoplasms (Breast Cancer)
08/2022 - 01/2003
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2015 - 10/2009
9Ischemic Stroke
04/2019 - 01/2006
9Hypoxia (Hypoxemia)
01/2019 - 07/2006
7Brain Ischemia (Cerebral Ischemia)
09/2021 - 01/2017
6Ischemia
11/2017 - 11/2011
5Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 10/2004
5Neoplasm Metastasis (Metastasis)
01/2022 - 05/2012
5Hypertension (High Blood Pressure)
10/2020 - 08/2003
5Transient Ischemic Attack
01/2018 - 11/2011
5Alzheimer Disease (Alzheimer's Disease)
01/2018 - 07/2005
5Inflammation (Inflammations)
10/2017 - 05/2011
5Hepatocellular Carcinoma (Hepatoma)
06/2013 - 01/2012
5Infections
10/2012 - 04/2010
4Cerebral Infarction
04/2019 - 10/2015
4Disease Progression
11/2013 - 03/2006
3Stroke (Strokes)
09/2021 - 01/2006
3Adenocarcinoma
11/2020 - 12/2009
3Carcinoma (Carcinomatosis)
11/2020 - 10/2004
3Hemorrhage
11/2018 - 11/2006
3Gliosis
11/2017 - 04/2012
3Lung Neoplasms (Lung Cancer)
10/2017 - 04/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2013 - 10/2005
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012 - 07/2005
3Parkinson Disease (Parkinson's Disease)
12/2011 - 05/2008
2Margins of Excision
08/2022 - 06/2007
2Body Weight (Weight, Body)
03/2022 - 04/2012
2Pneumonia (Pneumonitis)
02/2022 - 03/2010
2Noninfiltrating Intraductal Carcinoma (DCIS)
11/2021 - 06/2021
2Reperfusion Injury
09/2021 - 11/2017
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021 - 04/2003
2Necrosis
10/2020 - 01/2011
2Lymphatic Metastasis
09/2019 - 10/2018
2Ovarian Epithelial Carcinoma
11/2018 - 11/2018
2Thrombosis (Thrombus)
11/2018 - 05/2012
2Pathologic Constriction (Stenosis)
11/2018 - 01/2003
2Cognitive Dysfunction
01/2018 - 01/2018
2Infarction (Infarctions)
01/2017 - 10/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2016 - 10/2012

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2003
10Neuroprotective AgentsIBA
09/2021 - 03/2006
8ErbB Receptors (EGF Receptor)IBA
02/2012 - 12/2009
7Gefitinib (Iressa)FDA Link
03/2015 - 03/2010
5AntigensIBA
02/2020 - 03/2012
5Biomarkers (Surrogate Marker)IBA
01/2020 - 10/2005
4Hormones (Hormone)IBA
04/2022 - 01/2003
4Estrogen Receptor alphaIBA
03/2022 - 07/2006
4SteroidsIBA
02/2022 - 01/2003
4Glucose (Dextrose)FDA LinkGeneric
09/2021 - 12/2016
4Pharmaceutical PreparationsIBA
11/2018 - 10/2004
4CalciumIBA
11/2017 - 04/2012
4salicylhydroxamic acid (SHAM)IBA
11/2017 - 04/2012
4Estrogens (Estrogen)FDA Link
01/2017 - 01/2003
3Biological ProductsIBA
04/2022 - 10/2012
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2010
3Estrogen ReceptorsIBA
11/2021 - 07/2006
3Oxygen (Dioxygen)IBA
09/2021 - 12/2016
3Polylactic Acid-Polyglycolic Acid CopolymerIBA
02/2020 - 01/2016
3Small Interfering RNA (siRNA)IBA
10/2019 - 11/2018
3Phosphotransferases (Kinase)IBA
01/2019 - 12/2009
3Messenger RNA (mRNA)IBA
11/2018 - 01/2003
3Scopolamine (Hyoscine)FDA Link
01/2018 - 01/2018
3Glial Fibrillary Acidic ProteinIBA
11/2017 - 04/2012
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2017 - 12/2012
3Tyrosine Kinase InhibitorsIBA
11/2013 - 03/2010
3Glycogen Synthase (Synthase I)IBA
04/2013 - 07/2005
3DNA (Deoxyribonucleic Acid)IBA
10/2012 - 09/2002
3AntioxidantsIBA
05/2012 - 11/2011
3Levodopa (L Dopa)FDA LinkGeneric
12/2011 - 05/2008
2human ERBB2 proteinIBA
04/2022 - 01/2020
2Anti-Bacterial Agents (Antibiotics)IBA
02/2022 - 11/2021
2Matrix Metalloproteinases (MMPs)IBA
12/2021 - 01/2006
2Epidermal Growth Factor (EGF)IBA
12/2021 - 07/2011
2Progesterone Receptors (Progesterone Receptor)IBA
11/2021 - 09/2019
2TamoxifenFDA LinkGeneric
11/2021 - 09/2019
2Antihypertensive Agents (Antihypertensives)IBA
10/2020 - 10/2015
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2020 - 05/2011
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2020 - 04/2013
2VaccinesIBA
02/2020 - 12/2016
2Intracellular Signaling Peptides and ProteinsIBA
10/2019 - 10/2012
2polyacrylamideIBA
10/2019 - 10/2005
2Hyaluronic Acid (Hyaluronan)IBA
11/2018 - 11/2018
2ChitosanIBA
11/2018 - 12/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2017 - 10/2017
2fluoro jadeIBA
09/2017 - 04/2012
2Superoxide DismutaseIBA
08/2017 - 11/2011
2Superoxide Dismutase-1IBA
08/2017 - 07/2005
2LuciferasesIBA
07/2017 - 01/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2017 - 08/2003

Therapy/Procedure

12Therapeutics
01/2022 - 06/2007
8Drug Therapy (Chemotherapy)
10/2020 - 10/2009
5Liver Transplantation
04/2010 - 01/2003
4Hepatectomy
01/2021 - 11/2006
3Neoadjuvant Therapy
08/2022 - 01/2011
3Segmental Mastectomy (Lumpectomy)
08/2022 - 11/2006
3Chemoradiotherapy
10/2020 - 02/2010
3Immunotherapy
02/2020 - 01/2016
2Adjuvant Chemotherapy
12/2021 - 01/2011
2Radiotherapy
10/2020 - 02/2010